Trials that use: Interim analysis / alpha spending
New to this method? Read the tutorial →
11,819 results
- MIS-ABC SepsisIndependent statistical analysis of Mechanistic Inflammatory Sub-study Embedded Within the Albumin vs Balanced Crystalloid Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- misoIndependent statistical analysis of Misoprostol Prior to Intrauterine Device (IUD) Insertion in Nulliparous Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01147497).
- MISO200Independent statistical analysis of Misoprostol 400 µg Versus 200 µg for Cervical Ripening in 1st Trimester Miscarriage: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Misoprostol for Treatment of Fetal Death at 14-28 Weeks of Pregnancy: Complete Statistical AnalysisIndependent statistical analysis of Misoprostol for Treatment of Fetal Death at 14-28 Weeks of Pregnancy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Misoprostol With Intrauterine Device Insertion: Complete Statistical AnalysisIndependent statistical analysis of Misoprostol With Intrauterine Device Insertion: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00613366).
- Mission Connect Mild Traumatic Brain Injury (TBI) Integrated Clinical Protocol: Complete Statistical AnalysisIndependent statistical analysis of Mission Connect Mild Traumatic Brain Injury (TBI) Integrated Clinical Protocol: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01013870).
- MississippiIndependent statistical analysis of Study Evaluating the Safety and Efficacy of NCX 4251 Ophthalmic Suspension for the Treatment of Blepharitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- MISTICIndependent statistical analysis of Mirena Intrauterine System Timing of Insertion: A Randomized Controlled Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01272960).
- MISTIEIndependent statistical analysis of Minimally Invasive Surgery and rtPA for Intracerebral Hemorrhage Evacuation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00224770).
- MITIGATEIndependent statistical analysis of Study of Montelukast on Gastrointestinal Tolerability in Patients With Relapsing Forms of Multiple Sclerosis Receiving Tecfidera: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Mitigation of Postoperative Delirium in High-Risk Patients: Complete Statistical AnalysisIndependent statistical analysis of Mitigation of Postoperative Delirium in High-Risk Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05777187).
- MitoCKDIndependent statistical analysis of Mitochondria and Chronic Kidney Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03177798).
- MIVI-5Independent statistical analysis of Safety and Efficacy Study of Intravitreal Ocriplasmin in Subjects With AMD With Focal Vitreomacular Adhesion: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Mixture of Liposomal Bupivacaine and Bupivacaine for TAP Block for Open Hysterectomy: Complete Statistical AnalysisIndependent statistical analysis of Mixture of Liposomal Bupivacaine and Bupivacaine for TAP Block for Open Hysterectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- MK-1006 Single Dose Study in Japanese Type 2 Diabetes Patients (MK-1006-005): Complete Statistical AnalysisIndependent statistical analysis of MK-1006 Single Dose Study in Japanese Type 2 Diabetes Patients (MK-1006-005): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- MK-3475 Immunotherapy in Endometrial Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of MK-3475 Immunotherapy in Endometrial Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02630823).
- MK-7625A Plus Metronidazole Versus Meropenem in Pediatric Participants With Complicated Intra-Abdominal Infection (cIAI) (MK-7625A-035): Complete Statistical AnalysisIndependent statistical analysis of MK-7625A Plus Metronidazole Versus Meropenem in Pediatric Participants With Complicated Intra-Abdominal Infection (cIAI) (MK-7625A-035): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- MK-8527 Single-Dose Trial in HIV-1 Infected Participants (MK-8527-004): Complete Statistical AnalysisIndependent statistical analysis of MK-8527 Single-Dose Trial in HIV-1 Infected Participants (MK-8527-004): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05494736).
- MK0431 (Sitagliptin) Pioglitazone Add-on Study for Patients With Type 2 Diabetes Mellitus (0431-055)(COMPLETED): Complete Statistical AnalysisIndependent statistical analysis of MK0431 (Sitagliptin) Pioglitazone Add-on Study for Patients With Type 2 Diabetes Mellitus (0431-055)(COMPLETED): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- MK0431A Comparative Study in Patients With Type 2 Diabetes (0431A-079)(COMPLETED): Complete Statistical AnalysisIndependent statistical analysis of MK0431A Comparative Study in Patients With Type 2 Diabetes (0431A-079)(COMPLETED): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00482729).
- MK0507A Clinical Study in Patients With Glaucoma and Ocular Hypertension (0507A-149)(COMPLETED): Complete Statistical AnalysisIndependent statistical analysis of MK0507A Clinical Study in Patients With Glaucoma and Ocular Hypertension (0507A-149)(COMPLETED): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- MK0524B Bioequivalence Study (0524B-070): Complete Statistical AnalysisIndependent statistical analysis of MK0524B Bioequivalence Study (0524B-070): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00943124).
- MK2206 in Treating Patients With Advanced Refractory Biliary Cancer That Cannot Be Removed by Surgery: Complete Statistical AnalysisIndependent statistical analysis of MK2206 in Treating Patients With Advanced Refractory Biliary Cancer That Cannot Be Removed by Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- MLIndependent statistical analysis of Morning Light Treatment to Improve Glucose Metabolism: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03188263).
- mLab App Plus: A Randomized Controlled Trial of a Mobile Health (mHealth) Intervention: Complete Statistical AnalysisIndependent statistical analysis of mLab App Plus: A Randomized Controlled Trial of a Mobile Health (mHealth) Intervention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- mLIFEIndependent statistical analysis of The Mobile Lifestyle Intervention for Food and Exercise Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05176847).
- MLN8237 for Treatment of Participants With Ovarian, Fallopian Tube, or Peritoneal Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of MLN8237 for Treatment of Participants With Ovarian, Fallopian Tube, or Peritoneal Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- MMBIIndependent statistical analysis of Improving Balance and Mobility: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02374463).
- MMF for HIV Reservoir Reduction: Complete Statistical AnalysisIndependent statistical analysis of MMF for HIV Reservoir Reduction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03262441).
- MMFPRIMERIndependent statistical analysis of Mycophenolate Mofetil in Patients With Progressive Idiopathic Membranous Nephropathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01282073).
- MMNEIndependent statistical analysis of Effect of Medical Marijuana on Neurocognition and Escalation of Use: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03224468).
- MMPIndependent statistical analysis of Methadone Maintenance for Prisoners: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00378079).
- MMPHIndependent statistical analysis of Piloting Mindfulness Meditation Program for Underserved Racial Minority Adults With Pulmonary Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- MMPOWERIndependent statistical analysis of Safety, Tolerability, and Efficacy of MTP-131 for the Treatment of Mitochondrial Myopathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- MMRIndependent statistical analysis of A Comparative Study to Assess Efficacy of Intralesional MMR Vaccine and Intralesional Vitamin D3 in Treatment of Warts: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- MOBEIndependent statistical analysis of Motivated Behavior in Adults With and Without ADHD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02630017).
- Mobile – Bearing Knee Study: Complete Statistical AnalysisIndependent statistical analysis of Mobile - Bearing Knee Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00765362).
- Mobile Attention Retraining in Overweight Female Adolescents: Complete Statistical AnalysisIndependent statistical analysis of Mobile Attention Retraining in Overweight Female Adolescents: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02977403).
- Mobile WAChxIndependent statistical analysis of Mobile Strategies for Women's and Children's Health: Optimizing Adherence and Efficacy of PMTCT/ART: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- MOBILITYIndependent statistical analysis of Metformin for Overweight & OBese ChILdren and Adolescents With BDS Treated With SGAs: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- MOBILITY APIndependent statistical analysis of Trial to Evaluate the Safety & Efficacy of the Absolute Pro™ Peripheral Self-Expanding Stent System in Subjects With Atherosclerotic de Novo or Restenotic Lesions in the Native Common…
- Mobilization of Stem Cells With AMD3100 (Plerixafor) in Multiple Myeloma Patients: Complete Statistical AnalysisIndependent statistical analysis of Mobilization of Stem Cells With AMD3100 (Plerixafor) in Multiple Myeloma Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Mocetinostat (MGCD0103) Plus Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Hodgkin Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Mocetinostat (MGCD0103) Plus Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Hodgkin Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Mod-NalIndependent statistical analysis of Modafinil and Naltrexone to Reduce Cocaine and Alcohol Dependence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00142818).
- Modeling Stress-precipitated Smoking Behavior for Medication Development: Complete Statistical AnalysisIndependent statistical analysis of Modeling Stress-precipitated Smoking Behavior for Medication Development: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00773357).
- Moderate to Severe Plaque Psoriasis With Scalp Involvement: Complete Statistical AnalysisIndependent statistical analysis of Moderate to Severe Plaque Psoriasis With Scalp Involvement: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00791765).
- MODERNIndependent statistical analysis of Comparative Trial Of Maraviroc Versus Emtricitabine/Tenofovir Both With Darunavir/Ritonavir In Antiretroviral-Naive Patients Infected With CCR5 Tropic HIV 1: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Modernization of in vivo-in Vitro Oral Bioperformance Prediction and Assessment: Complete Statistical AnalysisIndependent statistical analysis of Modernization of in vivo-in Vitro Oral Bioperformance Prediction and Assessment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02806869).
- Modified Adaptive Servoventilation (ASV) Compared to Conventional ASV: Complete Statistical AnalysisIndependent statistical analysis of Modified Adaptive Servoventilation (ASV) Compared to Conventional ASV: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01405313).
- Modified Dakin’s Solution in Reducing Radiation-Induced Dermatitis in Patients With Head and Neck Cancer Undergoing Radiation Therapy: Complete Statistical AnalysisIndependent statistical analysis of Modified Dakin's Solution in Reducing Radiation-Induced Dermatitis in Patients With Head and Neck Cancer Undergoing Radiation Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…